Compounds > atorvastatin
Page last updated: 2024-08-24

atorvastatin and Glomerulonephritis

atorvastatin has been researched along with Glomerulonephritis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holdsworth, SR; Jones, LK; Kitching, AR; Phoon, RK1
Eller, K; Eller, P; Mayer, G; Patsch, JR; Reinstadler, SJ; Rosenkranz, AR; Tagwerker, A; Wolf, AM1
Al Nuaimi, H; Al-Ani, B; Savage, C1
Arisz, L; Kastelein, JJ; Koopman, MG; Ozsoy, RC1
Lavoie, S; Lipson, J; Zimmerman, D1

Other Studies

5 other study(ies) available for atorvastatin and Glomerulonephritis

ArticleYear
Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Nephrology (Carlton, Vic.), 2009, Volume: 14, Issue:7

    Topics: Animals; Atorvastatin; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Glomerulonephritis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunity, Humoral; Kidney; Male; Mice; Mice, Inbred C57BL; Pyrroles

2009
Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis.
    Kidney international, 2010, Volume: 77, Issue:5

    Topics: Animals; Atorvastatin; CD4-Positive T-Lymphocytes; Glomerular Basement Membrane; Glomerulonephritis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Interleukin-10; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Pyrroles; T-Lymphocyte Subsets; Th1 Cells

2010
The beneficial effects of statin therapy may not apply to all forms of crescentic glomerulonephritis.
    The American journal of pathology, 2011, Volume: 178, Issue:5

    Topics: Animals; Atorvastatin; Disease Models, Animal; Glomerulonephritis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Rats; Rats, Inbred WKY; Simvastatin

2011
The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis.
    Clinical nephrology, 2005, Volume: 63, Issue:4

    Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol; Chronic Disease; Creatinine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerulonephritis; Heptanoic Acids; Humans; Insulin; Insulin, Long-Acting; Insulin, Regular, Human; Lipoproteins; Male; Middle Aged; Proteinuria; Pyrroles; Retrospective Studies; Serum Albumin; Serum Albumin, Human; Time Factors; Treatment Outcome

2005
Gabapentin-induced myopathy in 2 patients on short daily hemodialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:6

    Topics: Adult; Amines; Anticonvulsants; Atorvastatin; Calcium Channels; Comorbidity; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neuromuscular Diseases; Peritoneal Dialysis; Physical Exertion; Postoperative Complications; Pyrroles; Recurrence; Renal Dialysis; Restless Legs Syndrome

2005